AXSM - Axsome Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart

AXSM is currently covered by 13 analysts with an average potential upside of $36.97 (65.12%) from yesterday's end of day stock price of $67.48. Axsome Therapeutics activity chart has currently 61 price targets and 99 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 48.12% with an average time for these price targets to be met of 84.29 days.

Highest price target for AXSM is $90, Lowest price target is $24, average price target is $57.

Most recent stock forecast was given by CHARLES DUNCAN from CANTOR FITZGERALD on 07-Nov-2023. First documented stock forecast 07-Jun-2018.

Currently, out of the existing stock ratings of AXSM - 38 which are a Buy (76%), 12 which are a Hold (24%)

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

108

$40.52 (60.05%)

108

27 days ago

7/13 (53.85%)

$21.93 (44.12%)

60

Buy

100

$32.52 (48.19%)

100

2 months 9 days ago

5/10 (50%)

$20.12 (29.32%)

122

Buy

180

$110.11 (157.55%)

190

3 months 26 days ago

2/12 (16.67%)

$103.76 (151.93%)

116

Buy

90

$22.52 (33.37%)

75

3 months 26 days ago

1/2 (50%)

$11.71 (16.35%)

26

Buy

110

$42.52 (63.01%)

90

5 months 19 days ago

4/8 (50%)

$39.98 (53.68%)

71

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is AXSM (Axsome Therapeutics) average time for price targets to be met?

On average it took 84.29 days on average for the stock forecasts to be realized with a an average price target met ratio 48.12

Which analyst has the current highest performing score on AXSM (Axsome Therapeutics) with a proven track record?

CHRIS HOWERTON

Which analyst has the most public recommendations on AXSM (Axsome Therapeutics)?

Chris Howerton works at JEFFERIES and has 3 price targets and 2 ratings on AXSM

Which analyst is the currently most bullish on AXSM (Axsome Therapeutics)?

Raghuram Selvaraju with highest potential upside - $110.11

Which analyst is the currently most reserved on AXSM (Axsome Therapeutics)?

Vamil Divan with lowest potential downside - -$18.48

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart